Status | Study |
Available |
Study Name: Treatment Use of 3,4 Diaminopyridine in Congenital Myasthenia and Lambert-Eaton Syndrome Condition: Congenital Myasthenic Syndrome Lambert-Eaton Myasthenic Syndrome Date: 2017-02-21 Interventions: Drug: 3,4-Diaminopyridine The investigator will prescribe an initial dose of 3,4 diaminopyridine (DAP) b |
Recruiting |
Study Name: Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS) Condition: Lambert-Eaton Myasthenic Syndrome Date: 2016-11-16 Interventions: Drug: Amifampridine Phosphate Drug: Placeb |
Recruiting |
Study Name: Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes Condition: Myasthenic Syndromes, Congenital Date: 2015-09-24 Interventions: Drug: amifampridine phosphate |
Active, not recruiting |
Study Name: Multicenter and Prospective Clinical Registry Study of Anti-N-methyl-D-aspartate Receptor Encephalitis in China Condition: Anti-NMDA Receptor Enphalitis Date: 2015-09-23 |
Available |
Study Name: Expanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS), Congenital Myasthenic Syndrome (CMS), or Downbeat Nystagmus Patients Condition: Lambert-Eaton Myasthenic Syndrome Congenital Myasthenic Syndrome Date: 2014-07-05 Interventions: Drug: Amifampridine Phosphate Dosage form: tablets contain |
Available |
Study Name: Use of 3,4-Diaminopyridine in the Treatment of Lambert-Eaton Syndrome Condition: Lambert Eaton Myasthenic Syndrome Date: 2013-03-22 Interventions: Drug: 3, 4-Diaminopyridine |
Available |
Study Name: Treatment Use of 3,4-Diaminopyridine Condition: Lambert Eaton Myasthenic Syndrome (LEMS) Myasthenic Syndromes, Congenital Date: 2013-01-06 Interventions: Drug: 3,4-diaminopyridine Trea |
Available |
Study Name: Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome Condition: Lambert-Eaton Myasthenic Syndrome Eaton-Lambert Myasthenic Syndrome Date: 2011-12-24 Interventions: Drug: 3,4-DAP Subjects will ma |
Completed |
Study Name: Pregnancy Outcomes in Congenital Myasthenie Syndrome Condition: Congenital Myasthenic Syndrome Date: 2011-11-16 |
No longer available |
Study Name: Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP Condition: Lambert Eaton Myasthenic Syndrome (LEMS) Date: 2011-06-20 Interventions: Drug: 3,4-diaminopyridine Treatment will begin with 5mg three times a day or less. |